|
🐜
|
Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19
44 auth.
Peng Zhang,
Lihua Zhu,
Jingjing Cai,
Fang Lei,
Juan-Juan Qin,
Jing Xie,
Ye Liu,
Yan-Ci Zhao,
Xuewei Huang,
Lijin Lin,
Meng Xia,
Ming-Ming Chen,
Xu Cheng,
Xiao Zhang,
D. Guo,
...
Yuanyuan Peng,
Yan‐Xiao Ji,
J. Chen,
Zhi‐Gang She,
Yibin Wang,
Qingbo Xu,
Renfu Tan,
Hai-tao Wang,
Jun Lin,
Pengcheng Luo,
Shouzhi Fu,
Hongbing Cai,
P. Ye,
B. Xiao,
W. Mao,
Liming Liu,
You-qin Yan,
Mingyu Liu,
Manhua Chen,
Xiao-Jing Zhang,
Xinghuan Wang,
R. Touyz,
J. Xia,
Bing-Hong Zhang,
Xiaodong Huang,
Yufeng Yuan,
L. Rohit,
Peter P. Liu,
Hongliang Li
|
10 |
2020 |
10
🐜
|
|
🐜
|
Longitudinal Association Between Markers of Liver Injury and Mortality in COVID‐19 in China
40 auth.
Fang Lei,
Ye Liu,
Feng Zhou,
Juan-Juan Qin,
Peng Zhang,
Lihua Zhu,
Xiao-Jing Zhang,
Jingjing Cai,
Lijin Lin,
Shan Ouyang,
Xiaoming Wang,
Chengzhang Yang,
Xu Cheng,
Weifang Liu,
Haomiao Li,
...
Jing Xie,
Bin Wu,
Huiming Luo,
F. Xiao,
J. Chen,
Liang Tao,
G. Cheng,
Zhi‐Gang She,
Jianghua Zhou,
Hai-tao Wang,
Jun Lin,
Pengcheng Luo,
Shouzhi Fu,
Jihui Zhou,
P. Ye,
B. Xiao,
W. Mao,
Liming Liu,
You-qin Yan,
Ling Liu,
Guohua Chen,
Hongliang Li,
Xiaodong Huang,
Bing-Hong Zhang,
Yufeng Yuan
|
8 |
2020 |
8
🐜
|
|
🐜
|
Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes
35 auth.
Xu Cheng,
Ye Liu,
Haomiao Li,
Xin Zhang,
Fang Lei,
Juan-Juan Qin,
Ze‐Dong Chen,
Ke-Qiong Deng,
Lijin Lin,
Ming-Ming Chen,
Xiaohui Song,
Meng Xia,
Xuewei Huang,
Weifang Liu,
Jingjing Cai,
...
Xiao-Jing Zhang,
Feng Zhou,
Peng Zhang,
Yibin Wang,
Xinliang Ma,
Qingbo Xu,
Juan Yang,
P. Ye,
W. Mao,
Xiaodong Huang,
J. Xia,
Bing-Hong Zhang,
Jiao Guo,
Lihua Zhu,
Zhibing Lu,
Yufeng Yuan,
Xiang Wei,
Zhi‐Gang She,
Yan‐Xiao Ji,
Hongliang Li
|
7 |
2020 |
7
🐜
|
|
🐜
|
Redefining Cardiac Biomarkers in Predicting Mortality of Inpatients With COVID-19
41 auth.
Juan-Juan Qin,
Xu Cheng,
Feng Zhou,
Fang Lei,
G. Akolkar,
Jingjing Cai,
Xiao-Jing Zhang,
A. Blet,
Jing Xie,
Peng Zhang,
Ye Liu,
Ziliang Huang,
Ling‐Ping Zhao,
Lijin Lin,
Meng Xia,
...
Ming-Ming Chen,
Xiaohui Song,
Liangjie Bai,
Ze‐Dong Chen,
Xingyuan Zhang,
Da Xiang,
Qingbo Xu,
Xinliang Ma,
R. Touyz,
Chen Gao,
Hai-tao Wang,
Liming Liu,
W. Mao,
Pengcheng Luo,
You-qin Yan,
P. Ye,
Manhua Chen,
Guohua Chen,
Lihua Zhu,
Zhi‐Gang She,
Xiaodong Huang,
Yufeng Yuan,
Bing-Hong Zhang,
Yibin Wang,
Peter P. Liu,
Hongliang Li
|
6 |
2020 |
6
🐜
|
|
🐜
|
The Neutrophil-to-Lymphocyte Ratio Determines Clinical Efficacy of Corticosteroid Therapy in Patients with COVID-19
39 auth.
Jingjing Cai,
Haomiao Li,
Changjiang Zhang,
Ze‐Dong Chen,
Hui Liu,
Fang Lei,
Juan-Juan Qin,
Ye Liu,
Feng Zhou,
Xiaohui Song,
Jianghua Zhou,
Yan-Ci Zhao,
Bin Wu,
Meiling He,
Huilin Yang,
...
Lihua Zhu,
Peng Zhang,
Yan‐Xiao Ji,
Guang-Nian Zhao,
Zhigang Lu,
Liming Liu,
W. Mao,
X. Liao,
Haofeng Lu,
Daihong Wang,
X. Xia,
Xiaodong Huang,
Xiang Wei,
J. Xia,
Bing-Hong Zhang,
Yufeng Yuan,
Zhi‐Gang She,
Qingbo Xu,
Xinliang Ma,
Yibin Wang,
Juan Yang,
Xin Zhang,
Xiao-Jing Zhang,
Hongliang Li
|
6 |
2021 |
6
🐜
|
|
🐜
|
Global Burden of Disease Study 2019 suggests that metabolic risk factors are the leading drivers of the burden of ischemic heart disease.
23 auth.
Wenxin Wang,
Manli Hu,
Hui Liu,
Xingyuan Zhang,
Haomiao Li,
Feng Zhou,
Ye Liu,
Fang Lei,
Juan-Juan Qin,
Yan-Ci Zhao,
...
Ze‐Dong Chen,
Weifang Liu,
Xiaohui Song,
Xuewei Huang,
Lihua Zhu,
Yan‐Xiao Ji,
Peng Zhang,
Xiao-Jing Zhang,
Zhi‐Gang She,
Juan Yang,
Hailong Yang,
Jingjing Cai,
Hongliang Li
|
6 |
2021 |
6
🐜
|
|
🐜
|
Hepatocyte TNF Receptor–Associated Factor 6 Aggravates Hepatic Inflammation and Fibrosis by Promoting Lysine 6–Linked Polyubiquitination of Apoptosis Signal‐Regulating Kinase 1
17 auth.
Yutao Wang,
Huan Wen,
Jiajun Fu,
Lin Cai,
Peng-Long Li,
Chang-Ling Zhao,
Zhu‐feng Dong,
Jun-Peng Ma,
Xi Wang,
Han Tian,
...
Yan Zhang,
Ye Liu,
Jingjing Cai,
Zhi‐Gang She,
Zan Huang,
Wenhua Li,
Hongliang Li
|
5 |
2020 |
5
🐜
|
|
🦁
|
Kidney Function Indicators Predict Adverse Outcomes of COVID-19
28 auth.
Ye Liu,
Jing Xie,
Ming-Ming Chen,
Xiao Zhang,
Xu Cheng,
Haomiao Li,
Feng Zhou,
Juan-Juan Qin,
Fang Lei,
Ze‐Dong Chen,
Lijin Lin,
Chengzhang Yang,
W. Mao,
Guohua Chen,
Haofeng Lu,
...
X. Xia,
Daihong Wang,
X. Liao,
Jun Yang,
Xiaodong Huang,
Bing-Hong Zhang,
Yufeng Yuan,
Jingjing Cai,
Xiao-Jing Zhang,
Yibin Wang,
Xin Zhang,
Zhi‐Gang She,
Hongliang Li
|
5 |
2020 |
5
🦁
|
|
🐜
|
Distributions and trends of the global burden of COPD attributable to risk factors by SDI, age, and sex from 1990 to 2019: a systematic analysis of GBD 2019 data
15 auth.
Jiahua Zou,
T. Sun,
Xiaohui Song,
Ye Liu,
Fang Lei,
Ming-Ming Chen,
Ze‐Dong Chen,
P. Zhang,
Yan‐Xiao Ji,
Xiao-Jing Zhang,
...
Zhi‐Gang She,
Jingjing Cai,
Yunman Luo,
Ping Wang,
Hongliang Li
|
5 |
2022 |
5
🐜
|
|
🐜
|
Hepatic Interferon Regulatory Factor 6 Alleviates Liver Steatosis and Metabolic Disorder by Transcriptionally Suppressing Peroxisome Proliferator‐Activated Receptor γ in Mice
15 auth.
Jingjing Tong,
Cuijuan Han,
Jia-Zhen Zhang,
Wenzhi He,
Guo-Jun Zhao,
Xu Cheng,
Ke-Qiong Deng,
Ye Liu,
Hui‐Fen Fan,
S. Tian,
...
Jingjing Cai,
Zan Huang,
Zhi‐Gang She,
Peng Zhang,
Hongliang Li
|
5 |
2019 |
5
🐜
|
|
🐜
|
Comparative impacts of angiotensin converting enzyme inhibitors versus angiotensin II receptor blockers on the risk of COVID-19 mortality.
32 auth.
Feng Zhou,
Ye Liu,
Jing Xie,
Haomiao Li,
Fang Lei,
Huilin Yang,
Juan-Juan Qin,
Jingjing Cai,
Xiao-Jing Zhang,
Bin Wu,
Meng Xia,
Da Xiang,
Chengzhang Yang,
Xinliang Ma,
Qingbo Xu,
...
Zhihong Lu,
Haofeng Lu,
X. Xia,
Daihong Wang,
X. Liao,
Gang Peng,
Jun Yang,
Xiaodong Huang,
Bing-Hong Zhang,
Yufeng Yuan,
Xiang Wei,
Peter P. Liu,
Yibin Wang,
Peng Zhang,
Zhi‐Gang She,
J. Xia,
Hongliang Li
|
5 |
2020 |
5
🐜
|
